WuXi Biologics (Cayman) Inc.
2269
Helyezés a részvények között
#987
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Részvényárfolyam
$5.77
Piaci kapitalizáció
$23.74B
Változás (1 nap)
-8.38%
Változás (1 év)
25.13%
Ország
CN
Kereskedés WuXi Biologics (Cayman) Inc. (2269)
Kategória
Healthcare
WuXi Biologics (Cayman) Inc. (2269) P/B aránya
P/B arány ekkor: October 2026 TTM: 3.28
WuXi Biologics (Cayman) Inc. legfrissebb pénzügyi jelentései és részvényára alapján a vállalat jelenlegi könyv szerinti árfolyam aránya (P/B, TTM) 3.28. 2024 végén ez az arány 1.61 volt.
P/B arány története a(z) WuXi Biologics (Cayman) Inc. esetén 2014 és 2026 között
P/B arány az év végén
| Év | P/B arány | Változtassa meg |
|---|---|---|
| 2026 (TTM) | 3.28 | 31.79% |
| 2025 | 2.49 | 54.96% |
| 2024 | 1.61 | -40.03% |
| 2023 | 2.68 | -57.33% |
| 2022 | 6.29 | -38.77% |
| 2021 | 10.28 | -41.50% |
| 2020 | 17.56 | 91.24% |
| 2019 | 9.18 | 26.97% |
| 2018 | 7.23 | -26.16% |
| 2017 | 9.80 | -90.76% |
| 2016 | 106.02 | -42.27% |
| 2015 | 183.65 | 166.79% |
| 2014 | 68.84 | 0.00% |
P/B arány hasonló vállalatoknál vagy versenytársaknál
| Vállalat | P/B arány | P/B arány különbség | Ország |
|---|---|---|---|
| 6.251 | 90.49% |
US
|
|
| 13.2547 | 303.92% |
US
|
|
| 4.208 | 28.23% |
AU
|
|
| 6.1824 | 88.40% |
NL
|
|
| - | - |
CH
|
